Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes

Molecular Therapy

Volumn 19, Issue 7, 2011, Pages 1331-1341

  Gonçalves, Manuel A F V ^a   Janssen, Josephine M ^a   Nguyen, Quynh G ^b   Athanasopoulos, Takis ^c   Hauschka, Stephen D ^b   Dickson, George ^c   De Vries, Antoine A F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CREATINE KINASE MM; DYSTROPHIN; MYOCARDIN; MYOD PROTEIN; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL FUSION; CELL LINEAGE; CELL MATURATION; CELL TRANSDIFFERENTIATION; CODON; CONTROLLED STUDY; DNA BINDING; DUCHENNE MUSCULAR DYSTROPHY; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MUSCLE CELL; MYOTUBE; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN MOTIF; REPORTER GENE; SKELETAL MUSCLE CELL;

EID: 79959989495     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.308     Document Type: Article

References (44)

1. Trollet, C, Athanasopoulos, T, Popplewell, L, Malerba, A and Dickson, G (2009). Gene therapy for muscular dystrophy: current progress and future prospects. Expert Opin Biol Ther 9: 849-866.
2. Partridge, T (2002). Myoblast transplantation. Neuromuscul Disord 12 Suppl 1: S3-S6. (Pubitemid 36158764)
3. Webster, C and Blau, HM (1990). Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat Cell Mol Genet 16: 557-565.
4. P?ult, B, Rudnicki, M, Torrente, Y, Cossu, G, Tremblay, JP, Partridge, T et al. (2007). Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 15: 867-877. (Pubitemid 46621645)
5. Ferrari, G, Stornaiuolo, A and Mavilio, F (2001). Failure to correct murine muscular dystrophy. Nature 411: 1014-1015. (Pubitemid 32612316)
6. Shi, D, Reinecke, H, Murry, CE and Torok-Storb, B (2004). Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood 104: 290-294. (Pubitemid 38879870)
7. Gon?lves, MAFV, de Vries, AAF, Holkers, M, van de Watering, MJM, van der Velde, I, van Nierop, GP et al. (2006). Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Hum Mol Genet 15: 213-221. (Pubitemid 43125976)
8. Morosetti, R, Mirabella, M, Gliubizzi, C, Broccolini, A, De Angelis, L, Tagliafico, E et al. (2006). MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proc Natl Acad Sci USA 103: 16995-17000. (Pubitemid 44737366)
9. Pittenger, MF, Mackay, AM, Beck, SC, Jaiswal, RK, Douglas, R, Mosca, JD et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
10. Satija, NK, Singh, VK, Verma, YK, Gupta, P, Sharma, S, Afrin, F et al. (2009). Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med 13: 4385-4402.
11. Gonlves, MA, Swildens, J, Holkers, M, Narain, A, van Nierop, GP, van de Watering, MJ et al. (2008). Genetic complementation of human muscle cells via directed stem cell fusion. Mol Ther 16: 741-748. (Pubitemid 351426176)
12. Goudenege, S, Pisani, DF, Wdziekonski, B, Di Santo, JP, Bagnis, C, Dani, C et al. (2009). Enhancement of myogenic and muscle repair capacities of human adiposederived stem cells with forced expression of MyoD. Mol Ther 17: 1064-1072.
13. Meng, J, Adkin, CF, Arechavala-Gomeza, V, Boldrin, L, Muntoni, F and Morgan, JE (2010). The contribution of human synovial stem cells to skeletal muscle regeneration. Neuromuscul Disord 20: 6-15.
14. Lattanzi, L, Salvatori, G, Coletta, M, Sonnino, C, Cusella De Angelis, MG, Gioglio, L et al. (1998). High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest 101: 2119-2128. (Pubitemid 28244096)
15. Kimura, E, Han, JJ, Li, S, Fall, B, Ra, J, Haraguchi, M et al. (2008). Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy. Hum Mol Genet 17: 2507-2517.
16. Sancho, S, Mongini, T, Tanji, K, Tapscott, SJ, Walker, WF, Weintraub, H et al. (1993). Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy. N Engl J Med 329: 915-920. (Pubitemid 23275272)
17. Roest, PA, van der Tuijn, AC, Ginjaar, HB, Hoeben, RC, Hoger-Vorst, FB, Bakker, E et al. (1996). Application of in vitro Myo-differentiation of non-muscle cells to enhance gene expression and facilitate analysis of muscle proteins. Neuromuscul Disord 6: 195-202. (Pubitemid 26171262)
18. Roest, PA, Bakker, E, Fallaux, FJ, Verellen-Dumoulin, C, Murry, CE and den Dunnen, JT (1999). New possibilities for prenatal diagnosis of muscular dystrophies: forced myogenesis with an adenoviral MyoD-vector. Lancet 353: 727-728. (Pubitemid 29103816)
19. Fujii, I, Matsukura, M, Ikezawa, M, Suzuki, S, Shimada, T and Miike, T (2006). Adenoviral mediated MyoD gene transfer into fibroblasts: myogenic disease diagnosis. Brain Dev 28: 420-425. (Pubitemid 43949332)
20. Cooper, ST, Kizana, E, Yates, JD, Lo, HP, Yang, N, Wu, ZH et al. (2007). Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis. Neuromuscul Disord 17: 276-284. (Pubitemid 46528700)
21. Saito, T, Nakamura, A, Aoki, Y, Yokota, T, Okada, T, Osawa, M et al. (2010). Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient. PLoS ONE 5: e12239.
22. Zhu, B and Gulick, T (2004). Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity. Mol Cell Biol 24: 8264-8275. (Pubitemid 39167474)
23. Zhu, B, Ramachandran, B and Gulick, T (2005). Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain. J Biol Chem 280: 28749-28760. (Pubitemid 41105776)
24. Dickson, G, Peck, D, Moore, SE, Barton, CH and Walsh, FS (1990). Enhanced myogenesis in NCAM-transfected mouse myoblasts. Nature 344: 348-351.
25. Broccolini, A, Gidaro, T, Morosetti, R, Gliubizzi, C, Servidei, T, Pescatori, M et al. (2006). Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. J Neurochem 96: 777-789.
26. Salva, MZ, Himeda, CL, Tai, PW, Nishiuchi, E, Gregorevic, P, Allen, JM et al. (2007). Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Mol Ther 15: 320-329. (Pubitemid 46111882)
27. Gonlves, MA, Janssen, JM, Holkers, M and de Vries, AA (2010). Rapid and sensitive lentivirus vector-based conditional gene expression assay to monitor and quantify cell fusion activity. PLoS ONE 5: e10954.
28. Foster, H, Sharp, PS, Athanasopoulos, T, Trollet, C, Graham, IR, Foster, K et al. (2008). Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer. Mol Ther 16: 1825-1832.
29. Quenneville, SP, Chapdelaine, P, Skuk, D, Paradis, M, Goulet, M, Rousseau, J et al. (2007). Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol Ther 15: 431-438. (Pubitemid 46111895)
30. Graf, T and Enver, T (2009). Forcing cells to change lineages. Nature 462: 587-594.
31. Darabi, R, Gehlbach, K, Bachoo, RM, Kamath, S, Osawa, M, Kamm, KE et al. (2008). Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 14: 134-143. (Pubitemid 351214552)
32. Gang, EJ, Bosnakovski, D, Simsek, T, To, K and Perlingeiro, RC (2008). Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage. Exp Cell Res 314: 1721-1733.
33. Zhou, Q, Brown, J, Kanarek, A, Rajagopal, J and Melton, DA (2008). In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 455: 627-632.
34. Vierbuchen, T, Ostermeier, A, Pang, ZP, Kokubu, Y, Shof, TC and Wernig, M (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463: 1035-1041.
35. Horb, ME, Shen, CN, Tosh, D and Slack, JM (2003). Experimental conversion of liver to pancreas. Curr Biol 13: 105-115. (Pubitemid 36154337)
36. Cao, D, Wang, Z, Zhang, CL, Oh, J, Xing, W, Li, S et al. (2005). Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol Cell Biol 25: 364-376. (Pubitemid 40039826)
37. Li, HJ, Haque, Z, Lu, Q, Li, L, Karas, R and Mendelsohn, M (2007). Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation. Proc Natl Acad Sci USA 104: 4065-4070. (Pubitemid 47181579)
38. Mattei, E, Corbi, N, Di Certo, MG, Strimpakos, G, Severini, C, Onori, A et al. (2007). Utrophin up-regulation by an artificial transcription factor in transgenic mice. PLoS ONE 2: e774.
39. Lu, Y, Tian, C, Danialou, G, Gilbert, R, Petrof, BJ, Karpati, G et al. (2008). Targeting artificial transcription factors to the utrophin A promoter: effects on dystrophic pathology and muscle function. J Biol Chem 283: 34720-34727.
40. Di Certo, MG, Corbi, N, Strimpakos, G, Onori, A, Luvisetto, S, Severini, C et al. (2010). The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice. Hum Mol Genet 19: 752-760.
41. Gregorevic, P, Blankinship, MJ, Allen, JM and Chamberlain, JS (2008). Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice. Mol Ther 16: 657-664. (Pubitemid 351426166)
42. Yue, Y, Ghosh, A, Long, C, Bostick, B, Smith, BF, Kornegay, JN et al. (2008). A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol Ther 16: 1944-1952.
43. CudrMauroux, C, Occhiodoro, T, Kig, S, Salmon, P, Bernheim, L and Trono, D (2003). Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a duchenne myoblast cell line with long-term genotypic and phenotypic stability. Hum Gene Ther 14: 1525-1533. (Pubitemid 37357740)
44. van Tuyn, J, Pijnappels, DA, de Vries, AA, de Vries, I, van der Velde-van Dijke, I, Kna?-Shanzer, S et al. (2007). Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene. FASEB J 21: 3369-3379. (Pubitemid 47565555)